Gene · 771
Papers1,772
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 1,772
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Photocatalytic Degradation of Textile Dye on Blended Cellulose Acetate Membranes. | Polymers (Basel) | 2022 | 35160625 | PubTator, text mining | PubMed |
| Pioneer Role of Extracellular Vesicles as Modulators of Cancer Initiation in Progression, Drug Therapy, and Vaccine Prospects. | Cells | 2022 | 35159299 | PubTator, text mining | PubMed |
| Editorial on Special Issue "Advances and Novel Treatment Options in Metastatic Melanoma". | Cancers (Basel) | 2022 | 35158974 | PubTator, text mining | PubMed |
| Construction of genetic classification model for coronary atherosclerosis heart disease using three machine learning methods. | BMC Cardiovasc Disord | 2022 | 35151267 | PubTator, text mining | PubMed |
| Targeting hypoxia regulated sodium driven bicarbonate transporters reduces triple negative breast cancer metastasis. | Neoplasia | 2022 | 35150959 | PubTator, text mining | PubMed |
| In vivo development and single-cell transcriptome profiling of human brain organoids. | Cell Prolif | 2022 | 35141969 | PubTator, text mining | PubMed |
| Distinct molecular phenotypes involving several human diseases are induced by IFN-λ3 and IFN-λ4 in monocyte-derived macrophages. | Genes Immun | 2022 | 35115664 | PubTator, text mining | PubMed |
| Hydroxysafflor yellow A attenuates oxidative stress injury-induced apoptosis in the nucleus pulposus cell line and regulates extracellular matrix balance via CA XII. | Exp Ther Med | 2022 | 35069863 | PubTator, text mining | PubMed |
| First studies on tumor associated carbonic anhydrases IX and XII monoclonal antibodies conjugated to small molecule inhibitors. | J Enzyme Inhib Med Chem | 2022 | 35057692 | PubTator, text mining | PubMed |
| The Epithelial-Mesenchymal Transition at the Crossroads between Metabolism and Tumor Progression. | Int J Mol Sci | 2022 | 35054987 | PubTator, text mining | PubMed |
| Umbilical Cord Mesenchymal Stromal Cells for Cartilage Regeneration Applications. | Stem Cells Int | 2022 | 35035489 | PubTator, text mining | PubMed |
| Potential of phytocompounds from Brassica oleracea targeting S2-domain of SARS-CoV-2 spike glycoproteins: Structural and molecular insights. | J Mol Struct | 2022 | 35034979 | PubTator, text mining | PubMed |
| Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions. | J Evid Based Integr Med | 2022 | 35018864 | PubTator, text mining | PubMed |
| Discovery of 2,4-thiazolidinedione-tethered coumarins as novel selective inhibitors for carbonic anhydrase IX and XII isoforms. | J Enzyme Inhib Med Chem | 2022 | 34991416 | PubTator, text mining | PubMed |
| Carbonic anhydrase and soluble adenylate cyclase regulation of cystic fibrosis cellular phenotypes. | Am J Physiol Lung Cell Mol Physiol | 2022 | 34986321 | PubTator, text mining | PubMed |
| Beta-2 Adrenergic Receptor Gene Expression in HER2-Positive Early-Stage Breast Cancer Patients: A Post-hoc Analysis of the NCCTG-N9831 (Alliance) Trial. | Clin Breast Cancer | 2022 | 34980541 | PubTator, text mining | PubMed |
| Integrative Comparison of Burrows-Wheeler Transform-Based Mapping Algorithm with de Bruijn Graph for Identification of Lung/Liver Cancer-Specific Gene. | J Microbiol Biotechnol | 2022 | 34949753 | PubTator, text mining | PubMed |
| 2-Aminobenzoxazole-appended coumarins as potent and selective inhibitors of tumour-associated carbonic anhydrases. | J Enzyme Inhib Med Chem | 2022 | 34894971 | PubTator, text mining | PubMed |
| Application of the dual-tail approach for the design and synthesis of novel Thiopyrimidine-Benzenesulfonamide hybrids as selective carbonic anhydrase inhibitors. | Eur J Med Chem | 2022 | 34847409 | PubTator, text mining | PubMed |
| Gene-environment interaction identification via penalized robust divergence. | Biom J | 2022 | 34725857 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/771/papers?page=23